Thursday, 27 March 2014

Aspirin study looks for more participants in the Goulburn Valley

SPHPM researchers involved in a clinical trial which is seeking to find out if aspirin can delay or prevent cardiovascular disease, dementia and some cancers, are looking for more participants from the Goulburn Valley.
The study entitled ASPirin in Reducing Events in the Elderly (ASPREE), already has 150 residents from the Goulburn Valley involved in the trial, but they are looking to bring the number up to 500.

ASPREE is a randomised, double-blind placebo controlled study and it involves both males and females aged 70 years and older. Participants are randomly assigned to take either a low-dose aspirin tablet (100mg) or a placebo tablet for a period of 5 years.  It will, for the first time, analyse the risks and benefits of aspirin therapy in healthy older people.  Results of the ASPREE study should be known in 2018.

If you are interested in partaking in the clinical trial, please register your interest here.

No comments:

Post a Comment


Related Posts Plugin for WordPress, Blogger...